Apyx Medical Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Apyx Medical stock.
View analyst ratings for Apyx Medical or view top-rated stocks.

Wall Street analysts have given Apyx Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Apyx Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Apyx Medical is scheduled to release its next quarterly earnings announcement on Wednesday, May 12th 2021.
View our earnings forecast for Apyx Medical.

Apyx Medical will be holding an earnings conference call on Wednesday, May 12th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Apyx Medical Co. (NASDAQ:APYX) announced its quarterly earnings data on Tuesday, March, 30th. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.07. Apyx Medical had a negative net margin of 64.16% and a negative trailing twelve-month return on equity of 24.21%.
View Apyx Medical's earnings history.

Apyx Medical's stock was trading at $5.06 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, APYX stock has increased by 90.5% and is now trading at $9.64.
View which stocks have been most impacted by COVID-19.

Apyx Medical issued an update on its FY 2021 Pre-Market earnings guidance on Wednesday, March, 31st. The company provided EPS guidance of for the period. The company issued revenue guidance of $36.7-38.7 million, compared to the consensus revenue estimate of $39.15 million.

3 Wall Street analysts have issued 1 year target prices for Apyx Medical's shares. Their forecasts range from $5.00 to $12.00. On average, they anticipate Apyx Medical's share price to reach $8.50 in the next twelve months. This suggests that the stock has a possible downside of 11.8%.
View analysts' price targets for Apyx Medical or view top-rated stocks among Wall Street analysts.

Some companies that are related to Apyx Medical include MiMedx Group (MDXG), Atrion (ATRI), SI-BONE (SIBN), Tactile Systems Technology (TCMD), Cerus (CERS), LeMaitre Vascular (LMAT), OrthoPediatrics (KIDS), AngioDynamics (ANGO), CryoLife (CRY), Orthofix Medical (OFIX), Surmodics (SRDX), OraSure Technologies (OSUR), Antares Pharma (ATRS), Intersect ENT (XENT) and Invo Bioscience (IVOB).
View all of APYX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), ONEOK (OKE), Occidental Petroleum (OXY), The Procter & Gamble (PG), STORE Capital (STOR), Wells Fargo & Company (WFC), The Boeing (BA), Bank of America (BAC) and Delta Air Lines (DAL).

Apyx Medical trades on the NASDAQ under the ticker symbol "APYX."

Apyx Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Calamos Advisors LLC (0.32%) and Wolff Wiese Magana LLC (0.11%).
View institutional ownership trends for Apyx Medical.

APYX stock was sold by a variety of institutional investors in the last quarter, including Wolff Wiese Magana LLC.
View insider buying and selling activity for Apyx Medical or view top insider-selling stocks.

APYX stock was purchased by a variety of institutional investors in the last quarter, including Calamos Advisors LLC.
View insider buying and selling activity for Apyx Medical or or view top insider-buying stocks.

Shares of APYX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of APYX stock can currently be purchased for approximately $9.64.

Apyx Medical has a market capitalization of $330.83 million and generates $28.15 million in revenue each year. The company earns $-19,710,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis.

Apyx Medical employs 266 workers across the globe.

The official website for Apyx Medical is www.apyxmedical.com.

Apyx Medical is headquartered at 5115 Ulmerton Road, Clearwater FL, 33760.

Apyx Medical's mailing address is 5115 Ulmerton Road, Clearwater FL, 33760. The company can be reached via phone at 727-384-2323 or via email at [email protected]